Opperman, K. J. | bioRxiv Science

bioRxiv2026

Geroprotective drug discovery with an AI-enabled assay for heat resistance

Drugs that slow the rate of organismal aging (geroprotectors) have the potential to improve human healthspan by preventing the development of multiple chronic diseases. The nematode C. elegans is a proven system for identifying anti-aging drugs, but methods for candidate nomination that scale to high throughput remain limited and have not been widely adopted. To accelerate the discovery process, we have developed an open-source AI-enabled screening platform that provides a rapid, automated, posture-based score of C. elegans survival. We used this workflow to screen a library of 2,782 FDA-approved drugs and identified 31 compounds that reproducibly increase heat stress resistance, a known predictor of longevity. Follow-up studies confirmed that many of these compounds confer lifespan extension in worms, and several compounds also have anti-senescent activity in human cells. This simplified and adaptable AI-enabled workflow therefore has the potential to accelerate the discovery of translatable drugs that slow aging.

pharmacology and toxicology↗

bioRxiv2025

UBR-1 enzyme network regulates glutamate homeostasis to affect organismal behavior and developmental viability

Johanson-Blizzard Syndrome (JBS) is an autosomal recessive spectrum disorder associated with the UBR-1 ubiquitin ligase that features developmental delay including motor abnormalities. Here, we demonstrate that C. elegans UBR-1 regulates high-intensity locomotor behavior and developmental viability via both ubiquitin ligase and scaffolding mechanisms. Super-resolution imaging with CRISPR-engineered UBR-1 and genetic results demonstrated that UBR-1 is expressed and functions in the nervous system including in pre-motor interneurons. To decipher mechanisms of UBR-1 function, we deployed CRISPR-based proteomics using C. elegans which identified a cadre of glutamate metabolic enzymes physically associated with UBR-1 including GLN-3, GOT-2.2, GFAT-1 and GDH-1. Similar to UBR-1, all four glutamate enzymes are genetically linked to human developmental and neurological deficits. Proteomics, multi-gene interaction studies, and pharmacological findings indicated that UBR-1, GLN-3 and GOT-2.2 form a signaling axis that regulates glutamate homeostasis. Developmentally, UBR-1 is expressed in embryos and functions with GLN-3 to regulate viability. Overall, our results suggest UBR-1 is an enzyme hub in a GOT-2.2/UBR-1/GLN-3 axis that maintains glutamate homeostasis required for efficient locomotion and organismal viability. Given the prominent role of glutamate within and outside the nervous system, the UBR-1 glutamate homeostatic network we have identified could contribute to JBS etiology.

neuroscience↗